Library
PubMed Central Open Access
research article
Professional
Open access

Frontline staff experiences of bridging dual diagnosis treatments – Determinants for implementing a cross-sectoral collaboration model

Source: PubMed Central Open Access, NCBI / U.S. National Library of Medicine

Addiction Science & Clinical PracticeLast synced 6/1/2026Status: syncedPMID: 42216031 pmidDOI: 10.1186/s13722-026-00681-3

Background It is estimated that 30–70% of patients in psychiatry have co-existing psychiatric disorders and substance use disorders, also called dual diagnosis. This condition often results in a complex clinical condition that affects the treatment trajectory and outcomes. Although the two conditions are intertwined, they are handled in two different sectors in Denmark, and therefore mostly treated separately. To overcome this divide, a coordination model was developed, with the aim of coordinating treatment between psychiatric outpatient FACT teams and municipal substance use treatment facilities for patients with dual diagnosis. The aim of this study was to assess the barriers and facilitators to a cross-sectoral coordination model as perceived by frontline staff during implementation. Methods 24 semi-structured interviews with frontline staff were performed in both sectors. The interview guide and analysis are based on the(CFIR) in combination with. Results During implementation of the coordination model, frontline staff perceived barriers and facilitators in outpatient psychiatry and substance use treatment centers within all domains of CFIR, yet overall, participants were positive about the benefits and potentials of the model. During implementation they experienced an improvement in coordination practices, although patients were still rejected despite use of implementation strategies aimed at knowledge and skills, staff in both sectors did not feel competent to treat th

Abstract

Background It is estimated that 30–70% of patients in psychiatry have co-existing psychiatric disorders and substance use disorders, also called dual diagnosis. This condition often results in a complex clinical condition that affects the treatment trajectory and outcomes. Although the two conditions are intertwined, they are handled in two different sectors in Denmark, and therefore mostly treated separately. To overcome this divide, a coordination model was developed, with the aim of coordinating treatment between psychiatric outpatient FACT teams and municipal substance use treatment facilities for patients with dual diagnosis. The aim of this study was to assess the barriers and facilitators to a cross-sectoral coordination model as perceived by frontline staff during implementation. Methods 24 semi-structured interviews with frontline staff were performed in both sectors. The interview guide and analysis are based on the(CFIR) in combination with. Results During implementation of the coordination model, frontline staff perceived barriers and facilitators in outpatient psychiatry and substance use treatment centers within all domains of CFIR, yet overall, participants were positive about the benefits and potentials of the model. During implementation they experienced an improvement in coordination practices, although patients were still rejected despite use of implementation strategies aimed at knowledge and skills, staff in both sectors did not feel competent to treat the target group and called for more training and concrete action plans. The flexibility required by this target group was considered hard to attain due to a lack of time and staff resources. Conclusion According to frontline staff, a sustainable effort and stronger cross-sector collaboration calls for extensive management support, an ongoing focus on culture- and behavior changes, and enhancement of competences associated with addressing, detecting, and treating dual diagnosis. Supplementary Information The online version contains supplementary material available at 10.1186/s13722-026-00681-3. Abs1

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.